BioSmart Co.,Ltd.
Financials
Valuation Metrics
BioSmart Co.,Ltd.'s Market Cap is ₩725B. At end of 2025 it was ₩986B. Ranked #1508 of 2,421 in KR market (top 62%), #880 of 1,640 on KOSDAQ (top 54%), #133 of 246 in Technology Hardware & Equipment (top 54%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 72.54B KRW | KR#1,508/2,421 Sec#133/246 |
| Revenue | 562.68B KRW | KR#581/2,421 Sec#33/246 |
| Net Income | 18.26B KRW | KR#737/2,421 Sec#58/246 |
| Total Assets | 345.35B KRW | KR#956/2,421 Sec#67/246 |
| Net Assets | 197.41B KRW | KR#954/2,421 Sec#71/246 |
| Employees | 163 | KR#1,253/2,421 Sec#93/246 |
| Value | ||
| P/E | 3.97x | KR#237/2,421 Sec#32/246 |
| P/B | 0.37x | KR#488/2,421 Sec#37/246 |
| PEG | 0.01x | KR#79/2,421 Sec#12/246 |
| P/S | 0.13x | KR#201/2,421 Sec#17/246 |
| EV/EBITDA | 4.46x | KR#187/2,421 Sec#22/246 |
| FCF Yield | -12.64% | KR—/2,421 Sec—/246 |
| Profitability | ||
| ROE | 9.25% | KR#676/2,421 Sec#79/246 |
| ROA | 5.29% | KR#703/2,421 Sec#90/246 |
| Op. Margin | 4.97% | KR#966/2,421 Sec#88/246 |
| Revenue Growth | -16.91% | KR#2,083/2,421 Sec#210/246 |
| Earnings Growth | 663.81% | KR#90/2,421 Sec#11/246 |
| Financial Health | ||
| Debt Ratio | 74.94% | KR#1,279/2,421 Sec#140/246 |
| Total Debt | 90.09B KRW | KR#765/2,421 Sec#54/246 |
| FCF | -9.17B KRW | KR#1,681/2,421 Sec#167/246 |
| Cash | 37.87B KRW | KR#881/2,421 Sec#76/246 |
| Current Ratio | 1.44x | KR#1,256/2,421 Sec#142/246 |
| Net Debt/EBITDA | 1.87x | KR#823/2,421 Sec#89/246 |
| Dividend | ||
| Div. Growth | 290.33% | KR#32/2,421 Sec#5/246 |
| Performance | ||
| 1Y Return | -7.87% | KR#915/2,421 Sec#116/246 |
| 1M Return | 12.55% | KR#397/2,421 Sec#70/246 |
| From 52W High | -58.59% | KR#1,803/2,421 Sec#181/246 |
| 1Y MDD | -62.80% | KR#1,634/2,421 Sec#139/246 |
| Trading | ||
| Volume | 98,667 shares | KR#788/2,421 Sec#90/246 |
| Trading Value | 282.8M KRW | KR#1,140/2,421 Sec#112/246 |
| Foreign Own. | 7.18% | KR#621/2,421 Sec#65/246 |
| Per Share | ||
| EPS | 723 KRW | KR#855/2,421 Sec#86/246 |
| BPS | 7,811 KRW | KR#1,139/2,421 Sec#104/246 |
Company Info
Listed on KOSDAQ in 2000, the company is a mid-sized enterprise with five consolidated subsidiaries. It operates businesses in smart cards, pharmaceuticals, alcohol payment, book publishing, diagnostic kits, and heavy electric equipment manufacturing and repair, seeking increased synergy by combining diverse industries. The smart card division leads the domestic IC card and smart card market and has obtained global card company approval. The pharmaceuticals division boasts a portfolio of approximately 300 types of professional and general pharmaceuticals. BIOSMART is headquartered in Seongdong-gu, Seoul.